Crigler-Najjar Syndrome Clinical Trials in Clamart
2 recruitingClamart, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Crigler-Najjar Syndrome
Genethon3 enrolled1 locationNCT06518005
Recruiting
Not Applicable
Gene Therapy for Severe Crigler Najjar Syndrome
Crigler-Najjar Syndrome
Genethon17 enrolled4 locationsNCT03466463